XTX Topco’s Acer Therapeutics Inc ACER Stock Holding History

XTX Topco’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,002	Closed	-$46K	–	1067
2021 Q3	$46K	Sell	18,002 -768	-4%	-$1.95K	0.02%	609
2021 Q2	$54K	Buy	+18,770	New	+$54K	0.02%	725

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

XTX Topco's ACER Position: Q4 2021 in Review

XTX Topco sold out of Acer Therapeutics Inc (ACER) in Q4 2021, closing a stake of 18,002 shares — an estimated $46K sold.

XTX Topco first reported a position in ACER in Q2 2021 and held it in 2 quarters. The position peaked at $54K in Q2 2021. 24 funds tracked by Wall St. Rank hold ACER as of Q4 2021.

XTX Topco reported no remaining Acer Therapeutics Inc position as of Q4 2021 after selling out during the quarter.
XTX Topco sold 18,002 Acer Therapeutics Inc shares in Q4 2021, an estimated $46K.
XTX Topco first reported a position in Acer Therapeutics Inc in Q2 2021 and held it in 2 quarters.
XTX Topco's Acer Therapeutics Inc position peaked at $54K in Q2 2021.
24 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2021.

Based on XTX Topco's 13F filing for Q4 2021, filed 11 Feb 2022.